Related references
Note: Only part of the references are listed.Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
Christian Labenz et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review
Jenny Lee et al.
LIVER INTERNATIONAL (2021)
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population
Yochai Schonmann et al.
DIGESTIVE AND LIVER DISEASE (2021)
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
Renaud La Joie et al.
NEUROLOGY (2021)
The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography
Justin S. Sanchez et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study
Yariv Gerber et al.
BMC GASTROENTEROLOGY (2021)
Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment
Alexandra L. Clark et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Natural History of NAFLD
Raluca Pais et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Non-alcoholic fatty liver disease
Elizabeth E. Powell et al.
LANCET (2021)
Early detection of amyloid load using 18F-florbetaben PET
Santiago Bullich et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Liver Bile Acid Changes in Mouse Models of Alzheimer's Disease
Harpreet Kaur et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study
Vijay R. Varma et al.
PLOS MEDICINE (2021)
Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
Ying Shang et al.
JHEP REPORTS (2021)
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease
Hannes Hagstrom et al.
GASTROENTEROLOGY (2020)
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
Jorge Simon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
Enrico Fantoni et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging
Jonathan Graff-Radford et al.
NEUROLOGY (2020)
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
Giovanni Targher et al.
GUT (2020)
Circulating ceramide ratios and risk of vascular brain aging and dementia
Emer R. McGrath et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
Yasushi Honda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study
Laura S. Chiu et al.
LIVER INTERNATIONAL (2020)
Association of amyloid-beta CSF/PET discordance and tau load 5 years later
Juhan Reimand et al.
NEUROLOGY (2020)
Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects
David S. Knopman et al.
BRAIN (2019)
Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals
Hyemin Jang et al.
SCIENTIFIC REPORTS (2019)
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee et al.
HEPATOLOGY (2019)
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2019)
Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study
Galit Weinstein et al.
LIVER INTERNATIONAL (2019)
The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
Clifford R. Jack et al.
BRAIN (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease
Rik Ossenkoppele et al.
NEUROLOGY (2019)
Self-Reported Physical Activity and Relations to Growth and Neurotrophic Factors in Diabetes Mellitus: The Framingham Offspring Study
Nicole L. Spartano et al.
JOURNAL OF DIABETES RESEARCH (2019)
PET staging of amyloidosis using striatum
Bernard J. Hanseeuw et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study
Galit Weinstein et al.
JAMA NEUROLOGY (2018)
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
Stuart McPherson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels-Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance
Ye-Ran Wang et al.
MOLECULAR NEUROBIOLOGY (2017)
Liver Fibrosis Scores Predict Liver Disease Mortality in the United States Population
Aynur Unalp-Arida et al.
HEPATOLOGY (2017)
Midlife Systemic Inflammation, Late-Life White Matter Integrity, and Cerebral Small Vessel Disease The Atherosclerosis Risk in Communities Study
Keenan A. Walker et al.
STROKE (2017)
Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy
Atsushi Takahashi et al.
PLOS ONE (2017)
Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic stroke
Seung Up Kim et al.
ATHEROSCLEROSIS (2017)
Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2016)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis
Veeravich Jaruvongvanich et al.
DIGESTIVE AND LIVER DISEASE (2016)
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Dong Hyun Sinn et al.
GASTROENTEROLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease
Salvatore Petta et al.
MEDICINE (2016)
Incidence of Dementia over Three Decades in the Framingham Heart Study
Claudia L. Satizabal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease
Yang Xiang et al.
ACTA NEUROPATHOLOGICA (2015)
Nonalcoholic Fatty Liver Disease and Vascular Function Cross-Sectional Analysis in the Framingham Heart Study
Michelle T. Long et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease
Ying Chen et al.
ATHEROSCLEROSIS (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
Jessica L. Mellinger et al.
JOURNAL OF HEPATOLOGY (2015)
Neuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation
Anne-Sophie Carret-Rebillat et al.
SCIENTIFIC REPORTS (2015)
Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2013)
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
Ebenezer T. Oni et al.
ATHEROSCLEROSIS (2013)
A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807
Timothy M. Shoup et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
Melania Gaggini et al.
NUTRIENTS (2013)
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice
Dimitrije Krstic et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Fatty Liver is Associated With Dyslipidemia and Dysglycemia Independent of Visceral Fat: The Framingham Heart Study
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study
Paolo Salvi et al.
JOURNAL OF HYPERTENSION (2010)
Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study
Elizabeth K. Speliotes et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
Silvia Sookoian et al.
JOURNAL OF HEPATOLOGY (2008)
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
Indra Neil Guha et al.
HEPATOLOGY (2008)
Abdominal visceral and subcutaneous adipose tissue compartments - Association with metabolic risk factors in the Framingham Heart Study
Caroline S. Fox et al.
CIRCULATION (2007)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
The third generation cohort of the national heart, lung, and blood institute's Framingham Heart Study: Design, recruitment, and initial examination
Greta Lee Splansky et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Rahul S. Desikan et al.
NEUROIMAGE (2006)
Share Paper
